自己免疫疾患治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Autoimmune Disorders Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8100346)・商品コード:GIR8100346
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年10月19日(※2024年版があります。お問い合わせください)
・ページ数:128
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、自己免疫疾患治療の世界市場について調べ、まとめました。種類別セグメントは、ブリッジ治療、組換え技術、糞便細菌療法、造血幹細胞移植、光線療法、その他等、用途別セグメントは、全身性自己免疫疾患、限局性自己免疫疾患等に区分しました。自己免疫疾患治療の世界市場概観、メーカー動向、メーカー別自己免疫疾患治療シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・自己免疫疾患治療の市場概観
・自己免疫疾患治療のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・自己免疫疾患治療のメーカー別販売動向、市場シェア、市場集中度、競争動向
・自己免疫疾患治療の世界市場規模
・自己免疫疾患治療の北米市場分析(アメリカ、カナダ、メキシコ等)
・自己免疫疾患治療のアメリカ市場規模推移
・自己免疫疾患治療のカナダ市場規模推移
・自己免疫疾患治療のメキシコ市場規模推移
・自己免疫疾患治療のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・自己免疫疾患治療のドイツ市場規模推移
・自己免疫疾患治療のイギリス市場規模推移
・自己免疫疾患治療のロシア市場規模推移
・自己免疫疾患治療のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・自己免疫疾患治療の日本市場規模推移
・自己免疫疾患治療の中国市場規模推移
・自己免疫疾患治療の韓国市場規模推移
・自己免疫疾患治療のインド市場規模推移
・自己免疫疾患治療の東南アジア市場規模推移
・自己免疫疾患治療の南米市場分析(ブラジル、アルゼンチン等)
・自己免疫疾患治療の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・自己免疫疾患治療の種類別分析/市場規模推移(ブリッジ治療、組換え技術、糞便細菌療法、造血幹細胞移植、光線療法、その他)
・自己免疫疾患治療の用途別分析/市場規模推移(全身性自己免疫疾患、限局性自己免疫疾患)
・自己免疫疾患治療の市場予測(地域別予測、種類別予測、用途別予測)
・自己免疫疾患治療の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Scope of the Report:

This report studies the Autoimmune Disorders Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Autoimmune Disorders Treatment market by product type and applications/end industries.

Graves’ disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in women than in men, which results from the influence of estrogen on immune system.

The global Autoimmune Disorders Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Autoimmune Disorders Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Abbott Laboratories

Roche Diagnostics

Siemens Healthcare

Johnson & Johnson

Boehringer Ingelheim

GlaxoSmithKline

AstraZeneca

Sanofi

Merck

Pfizer

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Bridge therapy

Recombinant technology

Fecal bacteriotherapy

Hematopoietic stem-cell transplantation

Phototherapy

Helminthic therapy

Activation-induced assays

Cytometry by time-of-flight mass spectrometry

Market Segment by Applications, can be divided into

Systemic autoimmune diseases

Localized autoimmune diseases

【レポートの目次】

Table of Contents

1 Autoimmune Disorders Treatment Market Overview

1.1 Product Overview and Scope of Autoimmune Disorders Treatment

1.2 Classification of Autoimmune Disorders Treatment by Types

1.2.1 Global Autoimmune Disorders Treatment Revenue Comparison by Types (2017-2023)

1.2.2 Global Autoimmune Disorders Treatment Revenue Market Share by Types in 2017

1.2.3 Bridge therapy

1.2.4 Recombinant technology

1.2.5 Fecal bacteriotherapy

1.2.6 Hematopoietic stem-cell transplantation

1.2.7 Phototherapy

1.2.8 Helminthic therapy

1.2.9 Activation-induced assays

1.2.10 Cytometry by time-of-flight mass spectrometry

1.3 Global Autoimmune Disorders Treatment Market by Application

1.3.1 Global Autoimmune Disorders Treatment Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Systemic autoimmune diseases

1.3.3 Localized autoimmune diseases

1.4 Global Autoimmune Disorders Treatment Market by Regions

1.4.1 Global Autoimmune Disorders Treatment Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Autoimmune Disorders Treatment Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Autoimmune Disorders Treatment Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Autoimmune Disorders Treatment Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Autoimmune Disorders Treatment Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Autoimmune Disorders Treatment Status and Prospect (2013-2023)

1.5 Global Market Size of Autoimmune Disorders Treatment (2013-2023)

2 Manufacturers Profiles

2.1 Abbott Laboratories

2.1.1 Business Overview

2.1.2 Autoimmune Disorders Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Laboratories Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.2 Roche Diagnostics

2.2.1 Business Overview

2.2.2 Autoimmune Disorders Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Roche Diagnostics Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.3 Siemens Healthcare

2.3.1 Business Overview

2.3.2 Autoimmune Disorders Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Siemens Healthcare Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.4 Johnson & Johnson

2.4.1 Business Overview

2.4.2 Autoimmune Disorders Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Johnson & Johnson Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.5 Boehringer Ingelheim

2.5.1 Business Overview

2.5.2 Autoimmune Disorders Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Boehringer Ingelheim Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.6 GlaxoSmithKline

2.6.1 Business Overview

2.6.2 Autoimmune Disorders Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 GlaxoSmithKline Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.7 AstraZeneca

2.7.1 Business Overview

2.7.2 Autoimmune Disorders Treatment Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 AstraZeneca Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.8 Sanofi

2.8.1 Business Overview

2.8.2 Autoimmune Disorders Treatment Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Sanofi Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.9 Merck

2.9.1 Business Overview

2.9.2 Autoimmune Disorders Treatment Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Merck Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.10 Pfizer

2.10.1 Business Overview

2.10.2 Autoimmune Disorders Treatment Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Pfizer Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 Global Autoimmune Disorders Treatment Market Competition, by Players

3.1 Global Autoimmune Disorders Treatment Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Autoimmune Disorders Treatment Players Market Share

3.2.2 Top 10 Autoimmune Disorders Treatment Players Market Share

3.3 Market Competition Trend

4 Global Autoimmune Disorders Treatment Market Size by Regions

4.1 Global Autoimmune Disorders Treatment Revenue and Market Share by Regions

4.2 North America Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

4.3 Europe Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

4.5 South America Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

5 North America Autoimmune Disorders Treatment Revenue by Countries

5.1 North America Autoimmune Disorders Treatment Revenue by Countries (2013-2018)

5.2 USA Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

5.3 Canada Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

5.4 Mexico Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

6 Europe Autoimmune Disorders Treatment Revenue by Countries

6.1 Europe Autoimmune Disorders Treatment Revenue by Countries (2013-2018)

6.2 Germany Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

6.3 UK Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

6.4 France Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

6.5 Russia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

6.6 Italy Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Autoimmune Disorders Treatment Revenue by Countries

7.1 Asia-Pacific Autoimmune Disorders Treatment Revenue by Countries (2013-2018)

7.2 China Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

7.3 Japan Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

7.4 Korea Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

7.5 India Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

8 South America Autoimmune Disorders Treatment Revenue by Countries

8.1 South America Autoimmune Disorders Treatment Revenue by Countries (2013-2018)

8.2 Brazil Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

8.3 Argentina Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

8.4 Colombia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Autoimmune Disorders Treatment by Countries

9.1 Middle East and Africa Autoimmune Disorders Treatment Revenue by Countries (2013-2018)

9.2 Saudi Arabia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

9.3 UAE Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

9.4 Egypt Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

9.5 Nigeria Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

9.6 South Africa Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

10 Global Autoimmune Disorders Treatment Market Segment by Type

10.1 Global Autoimmune Disorders Treatment Revenue and Market Share by Type (2013-2018)

10.2 Global Autoimmune Disorders Treatment Market Forecast by Type (2018-2023)

10.3 Bridge therapy Revenue Growth Rate (2013-2023)

10.4 Recombinant technology Revenue Growth Rate (2013-2023)

10.5 Fecal bacteriotherapy Revenue Growth Rate (2013-2023)

10.6 Hematopoietic stem-cell transplantation Revenue Growth Rate (2013-2023)

10.7 Phototherapy Revenue Growth Rate (2013-2023)

10.8 Helminthic therapy Revenue Growth Rate (2013-2023)

10.9 Activation-induced assays Revenue Growth Rate (2013-2023)

10.10 Cytometry by time-of-flight mass spectrometry Revenue Growth Rate (2013-2023)

11 Global Autoimmune Disorders Treatment Market Segment by Application

11.1 Global Autoimmune Disorders Treatment Revenue Market Share by Application (2013-2018)

11.2 Autoimmune Disorders Treatment Market Forecast by Application (2018-2023)

11.3 Systemic autoimmune diseases Revenue Growth (2013-2018)

11.4 Localized autoimmune diseases Revenue Growth (2013-2018)

12 Global Autoimmune Disorders Treatment Market Size Forecast (2018-2023)

12.1 Global Autoimmune Disorders Treatment Market Size Forecast (2018-2023)

12.2 Global Autoimmune Disorders Treatment Market Forecast by Regions (2018-2023)

12.3 North America Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)

12.4 Europe Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)

12.6 South America Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Autoimmune Disorders Treatment Picture

Table Product Specifications of Autoimmune Disorders Treatment

Table Global Autoimmune Disorders Treatment and Revenue (Million USD) Market Split by Product Type

Figure Global Autoimmune Disorders Treatment Revenue Market Share by Types in 2017

Figure Bridge therapy Picture

Figure Recombinant technology Picture

Figure Fecal bacteriotherapy Picture

Figure Hematopoietic stem-cell transplantation Picture

Figure Phototherapy Picture

Figure Helminthic therapy Picture

Figure Activation-induced assays Picture

Figure Cytometry by time-of-flight mass spectrometry Picture

Table Global Autoimmune Disorders Treatment Revenue (Million USD) by Application (2013-2023)

Figure Autoimmune Disorders Treatment Revenue Market Share by Applications in 2017

Figure Systemic autoimmune diseases Picture

Figure Localized autoimmune diseases Picture

Table Global Market Autoimmune Disorders Treatment Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table Abbott Laboratories Autoimmune Disorders Treatment Type and Applications

Table Abbott Laboratories Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Diagnostics Basic Information, Manufacturing Base and Competitors

Table Roche Diagnostics Autoimmune Disorders Treatment Type and Applications

Table Roche Diagnostics Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors

Table Siemens Healthcare Autoimmune Disorders Treatment Type and Applications

Table Siemens Healthcare Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Autoimmune Disorders Treatment Type and Applications

Table Johnson & Johnson Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors

Table Boehringer Ingelheim Autoimmune Disorders Treatment Type and Applications

Table Boehringer Ingelheim Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Autoimmune Disorders Treatment Type and Applications

Table GlaxoSmithKline Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Autoimmune Disorders Treatment Type and Applications

Table AstraZeneca Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Autoimmune Disorders Treatment Type and Applications

Table Sanofi Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Autoimmune Disorders Treatment Type and Applications

Table Merck Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Autoimmune Disorders Treatment Type and Applications

Table Pfizer Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Global Autoimmune Disorders Treatment Revenue (Million USD) by Players (2013-2018)

Table Global Autoimmune Disorders Treatment Revenue Share by Players (2013-2018)

Figure Global Autoimmune Disorders Treatment Revenue Share by Players in 2016

Figure Global Autoimmune Disorders Treatment Revenue Share by Players in 2017

Figure Global Top 5 Players Autoimmune Disorders Treatment Revenue Market Share in 2017

Figure Global Top 10 Players Autoimmune Disorders Treatment Revenue Market Share in 2017

Figure Global Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Autoimmune Disorders Treatment Revenue (Million USD) by Regions (2013-2018)

Table Global Autoimmune Disorders Treatment Revenue Market Share by Regions (2013-2018)

Figure Global Autoimmune Disorders Treatment Revenue Market Share by Regions (2013-2018)

Figure Global Autoimmune Disorders Treatment Revenue Market Share by Regions in 2017

Figure North America Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure Europe Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure South America Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Table North America Autoimmune Disorders Treatment Revenue by Countries (2013-2018)

Table North America Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)

Figure North America Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)

Figure North America Autoimmune Disorders Treatment Revenue Market Share by Countries in 2017

Figure USA Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure Canada Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure Mexico Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Table Europe Autoimmune Disorders Treatment Revenue (Million USD) by Countries (2013-2018)

Figure Europe Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)

Figure Europe Autoimmune Disorders Treatment Revenue Market Share by Countries in 2017

Figure Germany Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure UK Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure France Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure Russia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure Italy Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Autoimmune Disorders Treatment Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Autoimmune Disorders Treatment Revenue Market Share by Countries in 2017

Figure China Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure Japan Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure Korea Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure India Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Table South America Autoimmune Disorders Treatment Revenue by Countries (2013-2018)

Table South America Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)

Figure South America Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)

Figure South America Autoimmune Disorders Treatment Revenue Market Share by Countries in 2017

Figure Brazil Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure Argentina Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure Colombia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Autoimmune Disorders Treatment Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Autoimmune Disorders Treatment Revenue Market Share by Countries in 2017

Figure Saudi Arabia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure UAE Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure Egypt Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure Nigeria Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Figure South Africa Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)

Table Global Autoimmune Disorders Treatment Revenue (Million USD) by Type (2013-2018)

Table Global Autoimmune Disorders Treatment Revenue Share by Type (2013-2018)

Figure Global Autoimmune Disorders Treatment Revenue Share by Type (2013-2018)

Figure Global Autoimmune Disorders Treatment Revenue Share by Type in 2017

Table Global Autoimmune Disorders Treatment Revenue Forecast by Type (2018-2023)

Figure Global Autoimmune Disorders Treatment Market Share Forecast by Type (2018-2023)

Figure Global Bridge therapy Revenue Growth Rate (2013-2018)

Figure Global Recombinant technology Revenue Growth Rate (2013-2018)

Figure Global Fecal bacteriotherapy Revenue Growth Rate (2013-2018)

Figure Global Hematopoietic stem-cell transplantation Revenue Growth Rate (2013-2018)

Figure Global Phototherapy Revenue Growth Rate (2013-2018)

Figure Global Helminthic therapy Revenue Growth Rate (2013-2018)

Figure Global Activation-induced assays Revenue Growth Rate (2013-2018)

Figure Global Cytometry by time-of-flight mass spectrometry Revenue Growth Rate (2013-2018)

Table Global Autoimmune Disorders Treatment Revenue by Application (2013-2018)

Table Global Autoimmune Disorders Treatment Revenue Share by Application (2013-2018)

Figure Global Autoimmune Disorders Treatment Revenue Share by Application (2013-2018)

Figure Global Autoimmune Disorders Treatment Revenue Share by Application in 2017

Table Global Autoimmune Disorders Treatment Revenue Forecast by Application (2018-2023)

Figure Global Autoimmune Disorders Treatment Market Share Forecast by Application (2018-2023)

Figure Global Systemic autoimmune diseases Revenue Growth Rate (2013-2018)

Figure Global Localized autoimmune diseases Revenue Growth Rate (2013-2018)

Figure Global Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Autoimmune Disorders Treatment Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Autoimmune Disorders Treatment Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)

Figure Europe Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)

Figure South America Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)



【レポートのキーワード】

自己免疫疾患治療、ブリッジ治療、組換え技術、糞便細菌療法、造血幹細胞移植、光線療法、その他、全身性自己免疫疾患、限局性自己免疫疾患

★調査レポート[自己免疫疾患治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8100346)販売に関する免責事項を必ずご確認ください。
★調査レポート[自己免疫疾患治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆